fluorouracil has been researched along with myricetin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Austin, CP; Dorjsuren, D; Jadhav, A; Kulkarni, A; McNeill, DR; Shen, M; Simeonov, A; Wilson, DM | 1 |
| Iqbal, Z; Khuroo, T; Talegaonkar, S; Verma, D | 1 |
4 other study(ies) available for fluorouracil and myricetin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Identification and characterization of inhibitors of human apurinic/apyrimidinic endonuclease APE1.
Topics: Catalytic Domain; Cell Line; Coloring Agents; Deoxyribonuclease IV (Phage T4-Induced); DNA; DNA Damage; DNA-(Apurinic or Apyrimidinic Site) Lyase; Escherichia coli; Flavonoids; Fluorouracil; HeLa Cells; Humans; Models, Molecular; Recombinant Proteins; Triazines | 2009 |
Nanopotentiated combination cancer therapy: Chemotherapeutic and chemosensitizer (2C approach).
Topics: Antineoplastic Agents, Phytogenic; Curcumin; Drug Delivery Systems; Drug Therapy, Combination; Flavonoids; Fluorouracil; Humans; Models, Biological; Nanoparticles; Neoplasms; Resveratrol; Stilbenes | 2015 |